Document Detail


Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease.
MedLine Citation:
PMID:  14671465     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Lifestyle measures of coronary heart disease (CHD) prevention have been overshadowed by the efficacy of drug treatments. This is particularly the case in the setting of secondary prevention where the benefits of lipid lowering, anti-platelet and anti-hypertensive drugs have been emphasised in numerous trials. Lifestyle measures address several CHD risk factors at once and are generally free of serious side effects. OBJECTIVES: The objective of the present study was to determine whether a comprehensive programme of lifestyle modification could favourably influence dietary and exercise habits in addition to smoking cessation over two years. In addition, an attempt was made to evaluate if this programme could favourably influence the five-year CHD-risk in the male population included in the study. DESIGN: A total of 197 patients with proven coronary heart disease were included and randomised to a lifestyle intervention programme or to usual care. Follow-up was after a period of two years. METHODS: Intervention comprised a low fat diet, regular exercise, smoking cessation, psychosocial support and education, delivered by nurses on the rationale for pharmacological and lifestyle measures. Usual care comprised follow-up in the routine outpatient clinic. Both groups were given the same comprehensive medication according to recent guidelines. RESULTS: Patients in the lifestyle intervention group reduced the intake of saturated fat, sugar and cholesterol (P<0.001), increased their exercise level (P<0.01) and stopped smoking (P<0.05) when compared with the usual care group. A sub-analysis of the influence of five-year CHD calculated risk in males resulted in a relative risk reduction of 22% (95% confidence intervals 9-35). Although significant, this result must be interpreted with caution due to poor statistical power and reproducibility of the method. CONCLUSIONS: In the presence of modern drug treatments for secondary cardiovascular disease prevention it remains possible through a favourable diet, exercise and smoking cessation to show an additional reduction in the five-year risk for CHD in males.
Authors:
Related Documents :
12928465 - Major risk factors as antecedents of fatal and nonfatal coronary heart disease events.
6720665 - Ten-year incidence of coronary heart disease in the honolulu heart program. relationshi...
18523915 - Relationship between metabolic syndrome and its components with coronary heart disease ...
18380955 - Gender differences in cardiovascular disease prevention.
10447225 - Alarmingly high occurrence and case fatality of acute coronary heart disease events in ...
21238795 - Prevalence of taurodont and pyramidal molars in a german population.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology     Volume:  10     ISSN:  1741-8267     ISO Abbreviation:  Eur J Cardiovasc Prev Rehabil     Publication Date:  2003 Dec 
Date Detail:
Created Date:  2003-12-12     Completed Date:  2004-10-07     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  101192000     Medline TA:  Eur J Cardiovasc Prev Rehabil     Country:  England    
Other Details:
Languages:  eng     Pagination:  429-37     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Glucose
Blood Pressure / physiology
Cholesterol / blood
Cholesterol, Dietary / administration & dosage
Coronary Disease / prevention & control*
Counseling
Diet, Fat-Restricted
Dietary Sucrose / administration & dosage
Exercise
Fatty Acids / administration & dosage
Female
Follow-Up Studies
Health Behavior*
Hospitalization / statistics & numerical data
Humans
Life Style*
Male
Middle Aged
Norway
Nurse-Patient Relations
Patient Compliance
Risk Factors
Smoking Cessation
Chemical
Reg. No./Substance:
0/Blood Glucose; 0/Cholesterol, Dietary; 0/Dietary Sucrose; 0/Fatty Acids; 57-88-5/Cholesterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Relationship of electrocardiographic left ventricular hypertrophy to mortality and cardiovascular mo...
Next Document:  Blood pressure, serum total cholesterol and contraceptive pill use in 17-year-old girls.